Literature DB >> 21131221

Yersinia enterocolitica infection among children aged less than 12 years: a case-control study.

Iyad A El Qouqa1, Mahmoud A El Jarou, Ahmed S Abu Samaha, Ahmed S Al Afifi, Abdel Moati Kh Al Jarousha.   

Abstract

OBJECTIVES: A case-control study was conducted to identify risk factors, signs, and symptoms that may be associated with, Yersinia enterocolitica among children aged less than 12 years.
METHODS: From February 2006 to January 2007, stool samples from diarrhea cases with a clinical diagnosis of gastroenteritis and those of matched uninfected and infected controls, were examined for the presence of Y. enterocolitica.
RESULTS: Sixteen sporadic cases of Y. enterocolitica were identified. Of these, eight were detected in winter (December through February), while the remaining cases occurred in the spring, summer, and autumn. Of the 16 isolates, 10 belonged to serotype O:3, five belonged to serotype O:9, and one to serotype O:8. Compared to matched uninfected controls, multivariate analysis revealed that malnutrition (adjusted odds ratio (aOR) 6.23; p=0.002) and water supply (aOR 3.05; p=0.049) were independently associated with infection. Compared to infected controls, multivariate analysis showed malnutrition (aOR 3.53; p=0.027) to be an independent risk factor for the acquisition of yersiniosis. The antibiotic susceptibility profile showed that Y. enterocolitica was generally susceptible to meropenem (100%), ceftriaxone (94%), and ciprofloxacin (94%), followed by ceftazidime (88%) and amikacin (81%). Almost all Y. enterocolitica was resistant to ampicillin.
CONCLUSIONS: This study demonstrated that Y. enterocolitica occurs sporadically in children, with a predominance of serotypes O:3 and O:9. Furthermore malnutrition was identified as the main risk factor for yersiniosis. Copyright Â
© 2010 International Society for Infectious Diseases. Published by Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 21131221     DOI: 10.1016/j.ijid.2010.09.010

Source DB:  PubMed          Journal:  Int J Infect Dis        ISSN: 1201-9712            Impact factor:   3.623


  7 in total

1.  Yersinia enterocolitica, a Neglected Cause of Human Enteric Infections in Côte d'Ivoire.

Authors:  Daniel Saraka; Cyril Savin; Stephane Kouassi; Bakary Cissé; Eugène Koffi; Nicolas Cabanel; Sylvie Brémont; Hortense Faye-Kette; Mireille Dosso; Elisabeth Carniel
Journal:  PLoS Negl Trop Dis       Date:  2017-01-12

2.  Prevalence of Yersinia enterocolitica Bioserotype 3/O:3 among Children with Diarrhea, China, 2010-2015.

Authors:  Ran Duan; Junrong Liang; Jing Zhang; Yuhuang Chen; Jing Wang; Jing Tong; Bangcheng Guo; Wanfu Hu; Mingliu Wang; Jiayong Zhao; Chang Liu; Huijing Hao; Xin Wang; Huaiqi Jing
Journal:  Emerg Infect Dis       Date:  2017-09       Impact factor: 6.883

3.  Multilocular Hepatic Abscess Formation and Sepsis due to Yersinia enterocolitica in a Patient with Hereditary Hemochromatosis and Type 2 Diabetes Mellitus.

Authors:  Matthias Sauter; Stephan R Vavricka; Pascal Locher; Benjamin Preiswerk; Dominik Weishaupt; Christoph A Meier; Benjamin Misselwitz
Journal:  Case Rep Gastroenterol       Date:  2017-11-29

Review 4.  Toxigenic Properties of Yersinia enterocolitica Biotype 1A.

Authors:  Aleksandra Platt-Samoraj
Journal:  Toxins (Basel)       Date:  2022-02-05       Impact factor: 4.546

5.  Tracing genomic variations in two highly virulent Yersinia enterocolitica strains with unequal ability to compete for host colonization.

Authors:  Debora Garzetti; Hicham Bouabe; Juergen Heesemann; Alexander Rakin
Journal:  BMC Genomics       Date:  2012-09-11       Impact factor: 3.969

6.  Behavior of Yersinia enterocolitica in Foods.

Authors:  Md Latiful Bari; M Anwar Hossain; Kenji Isshiki; Dike Ukuku
Journal:  J Pathog       Date:  2011-10-23

Review 7.  Management strategies in the treatment of neonatal and pediatric gastroenteritis.

Authors:  Simona Ciccarelli; Ilaria Stolfi; Giuseppe Caramia
Journal:  Infect Drug Resist       Date:  2013-10-29       Impact factor: 4.003

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.